Amphastar Pharma(AMPH-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low18.60
Day High19.15
Open:18.97
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
StockStory
1 of Wall Street’s Favorite Stocks to Research Further and 2 Facing Challenges
ARLO
Tipranks
Analysts Offer Insights on Healthcare Companies: Schrodinger (SDGR), Amphastar Pharmaceuticals (AMPH) and COMPASS Pathways (CMPS)
Tipranks
FDA Issues Warning Letter to Amphastar Subsidiary IMS
Zacks Investment Research
New Strong Sell Stocks for June 23rd
New Strong Sell Stocks for June 23rd
StockStory
1 Healthcare Stock to Consider Right Now and 2 We Brush Off
RDNT
Tipranks
Amphastar Shareholders Approve Directors, Auditor and Pay Practices
Tipranks
Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Ardent Health Partners, Inc. (ARDT) and Amphastar Pharmaceuticals (AMPH)
MarketBeat
Amphastar Pharmaceuticals Sees Generic Atrovent Fueling 2026 Growth Despite BAQSIMI Drag
MarketBeat.com
ACCESS Newswire
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
StockStory
3 Stocks Under $50 with Open Questions
GCO
Tipranks
Amphastar Earnings Call Balances Growth and Margin Strain
StockStory
Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
AMPH
MarketBeat
Amphastar Pharmaceuticals Tackles BAQSIMI Discount Pressure, Keeps Sales Outlook
MarketBeat.com
StockStory
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
AMPH
StockStory
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment
AMPH
Tipranks
Amphastar Balances Margin Pain With Pipeline Gains
Tipranks
Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI), Amphastar Pharmaceuticals (AMPH) and Amylyx Pharmaceuticals Inc (AMLX)
Motley Fool
Amphastar (AMPH) Q1 2026 Earnings Transcript
MarketBeat
Amphastar Pharmaceuticals Q1 Earnings Call Highlights
MarketBeat.com

Profile

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.